BFLY
CVS

Larry Robbins

CIK: 0001228603

Larry Robbins's purchase track record

How the stock did after each of Larry Robbins's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
5
of 5 since March 15, 2022
Stock higher 6 months later
100%
3 months: 80%
Median 6-month return
+82.9%
3 months: +27.5%
Beat the S&P 500
100%
median +71.0% vs. index
PurchaseStockAmount3 months6 months
12/11/2025BFLY$64K+18.2%+84.4%
12/3/2025BFLY$4.65M+35.7%+47.8%
11/19/2025BFLY$6.78M+27.5%+82.9%
8/28/2024BFLY$1.95M+233.0%+301.8%
3/15/2022BFLY$2.25M-31.3%+36.9%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Butterfly Network Announces Long‑Term Alliance with VCOM and Gains New Coverage. Butterfly Network entered a long‑term partnership with the Edward Via College of Osteopathic Medicine to develop a new ultrasound education model. The collaboration aims to expand training tools for medical students. In addition, Canaccord Genuity started coverage on the stock, setting a price target of $10. The move reflects growing interest in Butterfly’s technology and its educational applications.

this person other insiders at BFLY

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.

this person other insiders at CVS

Transaction History

BFLY▼ Sell$5.2M
BFLY▼ Sell$7.2M
BFLY▼ Sell$2.1M
BFLY▼ Sell$4.6M
BFLY▼ Sell$1.6M
BFLY▼ Sell$1.3M
BFLY▼ Sell$12.7M
BFLY▲ Buy$0
CVS▼ Sell$34.6M
CVS▼ Sell$74.6M
CVS▼ Sell$14.5M
CVS▼ Sell$6.4M
CVS▼ Sell$77K
CVS▼ Sell$14K
CVS▼ Sell$187.3M
BFLY▲ Buy$64K
BFLY▲ Buy$611K
BFLY▲ Buy$1.6M
BFLY▲ Buy$2.4M
BFLY▲ Buy$2.1M
BFLY▲ Buy$2.4M
BFLY▲ Buy$2.4M
BFLY▲ Buy$0
CVS▼ Sell$10.0M
CVS▼ Sell$82.7M
CVS▼ Sell$6.6M
CVS▼ Sell$15.2M
CVS▼ Sell$26.0M
CVS▼ Sell$113.2M
BFLY▲ Buy$262K
BFLY▲ Buy$462K
BFLY▲ Buy$929K
BFLY▲ Buy$293K
BFLY▲ Buy$0
BFLY▲ Buy$0
BFLY▲ Buy$0
BFLY▲ Buy$2.3M
BFLY▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.